Sg Americas Securities, LLC Castle Biosciences Inc Transaction History

Sg Americas Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$22.51 - $34.32 $792,802 - $1.21 Million	-35,220 Reduced 89.44%	4,158 $108,000
Q2 2022 Jul 29, 2022	BUY	$16.0 - $45.99 $555,280 - $1.6 Million	34,705 Added 742.67%	39,378 $864,000
Q1 2022 Apr 29, 2022	SELL	$33.17 - $46.98 $117,886 - $166,966	-3,554 Reduced 43.2%	4,673 $210,000
Q4 2021 Feb 07, 2022	SELL	$39.06 - $67.58 $133,546 - $231,056	-3,419 Reduced 29.36%	8,227 $353,000
Q3 2021 Nov 01, 2021	BUY	$60.13 - $77.6 $548,024 - $707,246	9,114 Added 359.95%	11,646 $774,000

Q2 2021 Aug 12, 2021	SELL	$50.07 - $76.78 $3.12 Million - $4.79 Million	-62,344 Reduced 96.1%	2,532 $186,000
Q1 2021 May 13, 2021	BUY	$58.92 - $97.33 $241,513 - $398,955	4,099 Added 6.74%	64,876 $4.44 Million
Q4 2020 Feb 04, 2021	BUY	$43.6 - $73.05 $745,516 - $1.25 Million	17,099 Added 39.15%	60,777 $4.08 Million
Q3 2020 Nov 09, 2020	BUY	$38.47 - $52.03 $891,042 - $1.21 Million	23,162 Added 112.9%	43,678 $2.25 Million
Q2 2020 Jul 20, 2020	BUY	$27.28 - $43.01 $456,912 - $720,374	16,749 Added 444.62%	20,516 $773,000
Q1 2020 Apr 30, 2020	BUY	$23.08 - $35.53 $86,942 - $133,841	3,767 New	3,767 $112,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.